Bond.az White LogoBond.az Black Logo

CoreWeave Stock: AI Infrastructure Demand

Deutsche Bank reaffirms Buy rating on CoreWeave amid AI infrastructure demand. Key financials and market insights.

Aria Wright
ByAria Wright- Senior Editor
|
0

Bond.az - Deutsche Bank reiterated a Buy rating and $135 price target on CoreWeave (NASDAQ:CRWV). The stock trades at $105.49, with a market cap of $57.6 billion.

The firm noted that demand for AI infrastructure has boosted public cloud revenue and backlog, allowing established providers to accelerate and new entrants to scale.

Margins face pressure from a shift to lower-margin AI services and upfront costs. CoreWeave maintains a 69% gross margin but reported a loss of $3.15 per share over the past twelve months.

Deutsche Bank said CoreWeave's active contracts deliver attractive economic returns over their multi-year term.

More News
Today / 12:03
|
656

Tenable price target raised to $29

Stephens raised Tenable price target to $29, citing platform focus and AI opportunities. Tenable One adoption and new pricing are key catalysts.

0
Today / 12:01
|
683

PJM board letter positive for power producers

Melius Research sees PJM board letter as positive for independent power producers. Vistra shares up 16%, regulatory changes and market outlook.

0
Today / 11:03
|
631

Jefferies Raises SentinelOne Price Target to $24

Jefferies raised SentinelOne price target to $24 on margin outlook, maintaining Buy rating. Stock at $18.71, NNARR growth expected. Analyst sees H2 margin expansion.

0
Today / 11:02
|
566

ThinkEquity Initiates Atlas with Buy

ThinkEquity initiates Atlas Technical Consultants with a Buy rating and $15 target. The firm highlights the value of the Brazil critical-minerals option.

0
Today / 11:00
|
941

Reddit Stock Rating Boosted by App Growth

Citizens maintains Market Outperform on Reddit stock with $240 target. App installs surged 129% YoY, driving advertising growth.

0
Today / 10:33
|
492

Wolfe Research Reaffirms Ionis Stock Outperform Rating

Wolfe Research reiterates Outperform rating on Ionis Pharmaceuticals stock. Analysis of Arrowhead competition and financial results.

0
Today / 10:31
|
510

BTIG reiterates Uber Buy rating after Delivery Hero bid

BTIG reaffirms Uber Buy rating with $100 target after Delivery Hero bid. Stock seen as undervalued.

0
Today / 10:30
|
550

BTIG Reiterates Neutral on Affirm Stock

BTIG reiterates Neutral on Affirm stock amid credit trends. Analysis of delinquencies, growth prospects, and analyst targets.

0
Today / 10:02
|
707

Mizuho Cuts Intuit Target on TurboTax Weakness

Mizuho cuts Intuit target to $500 on TurboTax weakness; shares fall 20%. Read more on Bond.az.

0
Today / 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

0
Today / 06:02
|
602

Goldman Sachs Initiates Hemab Buy

Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.

0
Today / 06:01
|
425

Morgan Stanley Initiates Avalyn Pharma with Overweight

Morgan Stanley initiates Avalyn Pharma with Overweight rating and $53 target. The inhaled therapies AP01 and AP02 show promise in pulmonary fibrosis.

0
...
CoreWeave Stock: AI Infrastructure Demand | Bond.az